ALNYLAM PHARMACEUTICALS, INC.
SEC Filing List
ALNY CIK: 0001178670
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 8-K | Current report filing | Alnylam Pharmaceuticals, Inc. | Workiva Inc. Wdesk FA01 /fa | 04/30/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Alnylam Pharmaceuticals, Inc. | Workiva Inc. Wdesk FA01 /fa | 04/30/2026 | |
| SCHEDULE 13G | 04/29/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Mclaughlin Melissa | Alnylam Pharmaceuticals, Inc. | 04/07/2026 | |
| 3 | Initial statement of beneficial ownershi... | Mclaughlin Melissa | Alnylam Pharmaceuticals, Inc. | 04/07/2026 | |
| DEF 14A | Definitive proxy statements | Alnylam Pharmaceuticals, Inc. | Workiva Inc. Wdesk FA01 /fa | 04/06/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Alnylam Pharmaceuticals, Inc. | Workiva Inc. Wdesk FA01 /fa | 04/06/2026 | |
| ARS | Annual report to security holders | Alnylam Pharmaceuticals, Inc. | Broadridge Financial Solutions, Inc. /fa | 04/06/2026 | |
| 144 | Filing for proposed sale of securities u... | UBS Financial Services Inc Restricted Sale Group / FA /fa | 04/06/2026 | ||
| SCHEDULE 13G/A | 03/26/2026 | ||||
| No record found. | |||||
| Load More | |||||
